Professional Documents
Culture Documents
High-Yield Facts About Screening Tests
High-Yield Facts About Screening Tests
(NSAIDs) to prevent colorectal cancer in individuals at average risk for colorectal cancer.
Screening for Type 2 Diabetes Mellitus in Adults
fasting blood sugar
The USPSTF recommends screening for type 2 diabetes in asymptomatic adults with sustained blood
pressure (either treated or untreated) greater than 135/80 mm Hg.
*at age >45 year at 3 year interval
* <45 year of age with risk factor (HTN, family Hx, over weight, PCOS, Hx of gestational diabetes, low
HDL and high LDL)
In gestational Diabetes Mellitus, the best screening test is the 50 gram oral glucose tolerance test, not the
fasting glucose, and the confirmatory test is the 3 hour 100 gram glucose tolerance test.
Lipid screen:
fasting cholesterol and LDL
*Men= above 35 year
*Women=above 45 year in both done every 5 years
*in high risk patient start at age of 20 year, done every year
Screening for Carotid Artery Stenosis
The U.S. Preventive Services Task Force (USPSTF) recommends against screening for asymptomatic
carotid artery stenosis (CAS) in the general adult population.
The USPSTF recommends screening for osteoporosis in women aged 65 years or older and in younger
women whose fracture risk is equal to or greater than that of a 65-year-old white woman who has no
additional risk factors.
The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and
harms of screening for osteoporosis in men.
Barrett esophagus:
endoscopy
*only metaplasia= every 23 years
*low grade dysplasia= every 612 months
Screening for Asymptomatic Bacteriuria in Adults
The USPSTF recommends screening for asymptomatic bacteriuria with urine culture for pregnant women
at 12 to 16 weeks' gestation or at the first prenatal visit, if later.
Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions October 2012
The USPSTF recommends against the use of combined estrogen and progestin for the prevention of
chronic conditions in postmenopausal women.
The USPSTF recommends against the use of estrogen for the prevention of chronic conditions in
postmenopausal women who have had a hysterectomy.
In September 2012, the U.S. Food and Drug Administration approved the first ultrasound system,
the somo-v Automated Breast Ultrasound System (ABUS), for breast cancer screening specifically
in women with dense breast tissue. ABUS is indicated as an adjunct to standard mammography
for women with a negative mammogram, no breast cancer symptoms and no previous breast
intervention such as surgery or biopsy.